BiotechTube
Home/Be Biopharma/David Rawlings, M.D.
DR

David Rawlings, M.D.

Co-Founder

Be Biopharma

Therapeutic Areas

Rare DiseasesHematologyMetabolic Disorders

Be Biopharma Pipeline

DrugIndicationPhase
BE-101Hemophilia BPhase 1/2
BE-102HypophosphatasiaPreclinical

Leadership Team at Be Biopharma

RJ
Richard James, Ph.D.
Co-Founder
SA
Susan Abu-Absi, Ph.D.
Chief Operating Officer
View full Be Biopharma profile